PFN.N
Latest Trade
9.99USDChange
0.00(0.00%)Volume
24,088Today's Range
-
10.0152 Week Range
-
10.92As of on the New York Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 9.99 |
---|---|
Open | 9.99 |
Volume | 24,088 |
3M AVG Volume | 5.14 |
Today's High | 10.01 |
Today's Low | 9.98 |
52 Week High | 10.92 |
52 Week Low | 5.01 |
Shares Out (MIL) | 72.87 |
Market Cap (MIL) | 727.94 |
Forward P/E | -- |
Dividend (Yield %) | 9.61 |
PIMCO Income Strategy Fund II declares dividend
PIMCO Income Strategy Fund II Declares Monthly Common Share Dividend
Pimco Income Strategy Fund II Announces Terms Of Rights Offering
PIMCO Income Strategy Fund II (the Fund) is a closed-end management investment company. The Fund's primary investment objective is to seek high current income, consistent with the preservation of capital. The Fund allocates assets in varying proportions among floating- and fixed-rate debt instruments, as well as among investment grade and non-investment-grade securities. The Fund will not invest more than 20% of its total assets in securities that are, at the time of purchase, rated CCC/Caa or below by each ratings agency rating the security, or that are unrated but judged by PIMCO to be of comparable quality. The Fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, and short-term instruments. Pacific Investment Management Company LLC serves as the Funds' investment manager.
Industry
Misc. Financial Services
Contact Info
84 State St
BOSTON, MA
02109-2202
United States
+1.212.7394000
Executive Leadership
Deborah A. DeCotis
Independent Chairman of the Board, Trustee
Eric D. Johnson
President
Joshua D. Ratner
Senior Vice President
Peter G. Strelow
Senior Vice President
Keisha Audain-Pressley
Chief Compliance Officer
Price To Earnings (TTM) | -- |
---|---|
Price To Sales (TTM) | 10.60 |
Price To Book (MRQ) | 1.17 |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | 23.52 |
LT Debt To Equity (MRQ) | 0.00 |
Return on Investment (TTM) | -4.57 |
Return on Equity (TTM) | -3.60 |
With COVID-19 vaccine trial results looking positive, governments and pharmaceutical firms face their next daunting challenge: convincing the world to get inoculated.
Sales at Conagra Brands Inc <CAG.N> fell short of Wall Street estimates on Thursday as the packaged food company sold fewer products at full-price to restaurants and caterers, weakening profit and sending the company's shares lower.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.